Incyte
INCY
#979
Rank
$24.38 B
Marketcap
$119.65
Share price
1.39%
Change (1 day)
12.90%
Change (1 year)

Incyte (INCY) - Net assets

Net assets on the balance sheet as of September 2026 : $5.64 Billion USD

According to Incyte's latest financial reports the company has $5.64 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Incyte - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$$5.18 B18.76%
2022-12-31$$4.37 B15.92%
2021-12-31$$3.77 B44.37%
2020-12-31$$2.61 B0.49%
2019-12-31$$2.59 B34.91%
2018-12-31$$1.92 B18.11%
2017-12-31$$1.63 B288.74%
2016-12-31$$0.41 B145.08%
2015-12-31$$0.17 B-309.68%
2014-12-31$-$81.63 Million-57.73%
2013-12-31$-$0.2 Billion10.37%
2012-12-31$-$0.18 Billion-22.95%
2011-12-31$-$0.23 Billion156.17%
2010-12-31$-$88.65 Million-13.42%
2009-12-31$-$0.11 Billion-53.62%
2008-12-31$-$0.23 Billion38.39%
2007-12-31$-$0.16 Billion87.87%
2006-12-31$-$84.91 Million337.74%
2005-12-31$-$19.4 Million-124.7%
2004-12-31$$78.51 M-49.12%
2003-12-31$$0.15 B-48.97%
2002-12-31$$0.30 B-31.3%
2001-12-31$$0.44 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
$37.56 B 565.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$85.49 B 1,415.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$40.27 B 613.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.68 B 107.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$0.96 B-82.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.21 B-96.13%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-$25.35 Million-100.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$28.84 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$0.14 B-97.36%๐Ÿ‡บ๐Ÿ‡ธ USA